Healthcare HLA Typing Market is expected to grow at a CAGR of 6.5% during the forecasting period 2021...

HLA Typing Market is expected to grow at a CAGR of 6.5% during the forecasting period 2021-2027

HLA typing is a type of genetic test used to recognize few individual variations in a person’s immune system. The is a crucial process used for identifying which people can safely donate cord blood, bone marrow, or an organ to the person who requires a transplant. The long term for HLA is human leukocyte antigen, but it is mostly referred to as HLA. HLA typing is also sometimes known as HLA matching. The most common purpose for HLA typing is to assist in determining which people can donate the safest tissue transplants such as solid organ or hematopoietic stem cell transplantation. Possible tissue receivers must have the typing, as must anyone who might possibly want to provide tissue. This can include relatives of someone requiring a transplant. Furthermore, the implementation of advanced technologies and streamlining of healthcare processes in HLA typing will allow cost-saving in near future. On the other hand, the restricted government regulations for donations of organs and transplantations are happening to limit the market growth.

Request for a sample report:

Key Driving Factors:

HLA typing market is anticipated to observe considerable growth due to the increasing numbers of transplantation procedures and a rise in the number of older adult organ donors. The key reason for the increasing number of transplantations are rising awareness among the people about the organ transplantation and increasing number of chronic diseases or genetic organ defects such as congenital heart defect and polycystic kidney diseases. Moreover, the new market grants and relaxed government policies are also providing path to increased funding and research activities. Such processes, which are carried out by government, corporations or foundations, allot scarce funds. Independent research activities are increasing, which can result in growth of knowledge or process in an area, which can develop into a major project. This is set to propel the market growth.

The key leading players of the HLA typing market include Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Affymetrix, Inc., Immucor, Inc., Olerup SSP AB, Luminex Corporation, Qiagen N.V., Illumina, Inc., F. Hoffmann-LA-Roche Limited, Abbott Laboratories, Inc.

Opportunities: Technological Advancements in HLA Typing in Emerging Nations Will Create Lucrative Opportunities

Technological advancements will generate various opportunities for fostering development in the global HLA typing market. Technological advancements in health care facilities across emerging countries and increasing awareness about the organ donation and transplantation among public will present significant business growth prospects for the market. In addition, increasing public-private investments in technological innovation of product is also projected to generate enormous opportunities for the market.

By End User 

Based on end user, the market is bifurcated into independent reference laboratories, hospitals & transplant centers and research laboratories & academic institutes. The hospitals and transplant centers segment has the major market share, and is projected to grow majorly over the forecasted period. The factors can be ascribed for the increasing organ transplantation in the hospitals and transplant centers, due to the availability of advanced facilities, skilled professionals, increasing awareness about the transplantation and necessary infrastructure across the segment.

By Product and Service 

·        Reagents & Consumables

·        Instruments

·        Software & Services 

By Technology 

·    Molecular Assay Technologies

o  PCR-Based Molecular Assays

o   Sequence-specific oligonucleotide-PCR

o  Sequence-specific primer-PCR

o  Real-time PCR

o   Other PCR-based molecular assays

o   Sequencing-Based Molecular Assays

§  Sanger sequencing

§   Next-generation sequencing

§  Other sequencing-based molecular assays

o   Sequencing-Based Molecular Assay

·    Non-Molecular Assay Technologies 

By Application 

·        Diagnostic Applications

·        Antibody Screening

·        Chimerism Monitoring

·        Other Applications

·        Research Applications 

By End User 

·        Independent Reference Laboratories

·        Hospitals & Transplant Centers

·        Research Laboratories & Academic Institutes 

By Region 

·        North America

·        Europe

·        Asia Pacific

·        Rest of the World

Access to Full Report Summary:

Published Date : April-2021